Cross-institution positioning
Feb 11, 2026Reduction leaning. 1 exited across 1 comparable institution.
Source: Schedule 13 researchRERE Institutional Ownership
ATRenew Inc.
Latest stored close $3.76 as of Oct 9, 2026 View live quote ↗
STOCKNODE Outlook
Sell
30/100
1 tracked · 1 comparable
Latest filing
Feb 11, 2026
Positive breadth
0 positive · 1 negative
Recent close
$3.76
Research confidence
Limited
Institutional Research 25/100 · 0 accumulating · 1 reducing / exited
Ownership history
Reported ownership % history
Latest filing Feb 11, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating0
Newly reported0
Reducing / exited
1
52-week position
—
Institutional Intelligence
Why STOCKNODE says Sell
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Sell 30/100
Confidence:Limited
Why this signal
- 0 tracked institutions accumulating versus 1 reducing/exited.
Institutional
24/100
Insiders
50/100
Quarterly 13F activity
Jun 30, 20260 increased/new, 1 reduced/exited across 1 manager in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Aug 18, 2026Recent Forms 3/4/5 activity is available, with no non-amendment non-derivative SEC-coded P/S transactions in the rolling 90-day window. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Price context
Sep 15, 2026Recent close is 14% through its reported 52-week range; -11.3% over one year.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Schedule 13G amendment from Morgan Stanley.
Filed Feb 11, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Feb 11, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Morgan Stanley
Filed Feb 11, 2026
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Morgan Stanley
Filed Feb 11, 2026
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases00 reporting owner(s)
30-day sales00 reporting owner(s)
90-day purchase breadth0
90-day sale breadth0
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Chen Chen | AGrant, award, or other acquisition · derivative | Options (Right to Buy) | 4.1K | $0.00 | Direct | Aug 20, 2026 |
| Aug 18, 2026 | Chen Chen | AGrant, award, or other acquisition · derivative | Options (Right to Buy) | 14.5K | $0.00 | Direct | Aug 20, 2026 |
| Aug 18, 2026 | Chen Chen | AGrant, award, or other acquisition · derivative | Options (Right to Buy) | 64.2K | $0.00 | Direct | Aug 20, 2026 |
| Aug 18, 2026 | Chen Chen | AGrant, award, or other acquisition · derivative | Options (Right to Buy) | 5.6K | $0.00 | Direct | Aug 20, 2026 |
| Aug 18, 2026 | Chen Chen | AGrant, award, or other acquisition · derivative | Options (Right to Buy) | 3.3K | $0.00 | Direct | Aug 20, 2026 |
| Aug 18, 2026 | Wang Yongliang | AGrant, award, or other acquisition · derivative | Options (Right to Buy) | 5.7K | $0.00 | Direct | Aug 20, 2026 |
| Aug 18, 2026 | Wang Yongliang | AGrant, award, or other acquisition · derivative | Options (Right to Buy) | 38.0K | $0.00 | Direct | Aug 20, 2026 |
| Aug 18, 2026 | Wang Yongliang | AGrant, award, or other acquisition · derivative | Options (Right to Buy) | 7.0K | $0.00 | Direct | Aug 20, 2026 |
| Aug 18, 2026 | Wang Yongliang | AGrant, award, or other acquisition · derivative | Options (Right to Buy) | 76.8K | $0.00 | Direct | Aug 20, 2026 |
| Aug 18, 2026 | Wang Yongliang | AGrant, award, or other acquisition · derivative | Options (Right to Buy) | 7.8K | $0.00 | Direct | Aug 20, 2026 |
| Aug 18, 2026 | Wang Yongliang | AGrant, award, or other acquisition · derivative | Options (Right to Buy) | 11.6K | $0.00 | Direct | Aug 20, 2026 |
| Aug 18, 2026 | Wang Yongliang | AGrant, award, or other acquisition · derivative | Options (Right to Buy) | 12.2K | $0.00 | Direct | Aug 20, 2026 |
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$3.91
View live quote ↗
52-week low
$3.50
Jun 23, 2026
52-week high
$6.47
Jan 12, 2026
Below 52-week high
39.6%
1W return
-3.9%
1M return
-14.1%
3M return
-3.0%
6M return
-30.8%
YTD return
-26.2%
1Y return
-11.3%
30-day volatility
47.4%
90-day volatility
52.8%
1Y max drawdown
-42.9%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 3 filing(s)View beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Morgan Stanley CIK0000895421 | Dec 31, 2025 observed Feb 11, 2026 filed · 42d Schedule 13G amendment | Exit below reporting threshold | 4.0M -914.2K | 4.50% -1.10 pts | $5.30 | $5.81 | $3.76 |
| Morgan Stanley CIK0000895421 | Dec 31, 2024 observed Feb 5, 2025 filed · 36d Initial Schedule 13G | Initial Schedule 13G | 4.9M | 5.60% | $2.88 | $2.87 | $3.76 |
| Morgan Stanley CIK0000895421 | Sep 30, 2021 quarter end Nov 15, 2021 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 22.1K | $3.76 |
Explore more institutional activity
Related research
Compare RERE with other securities showing similar institutional activity or recent accumulation across several tracked institutions.